Skip to main content
All lobbying filings

Forbes-Tate

Forbes-Tate filed a Q1 report for Independent Pharmacy Cooperative on April 15, 2025, reporting $30,000 in lobbying income.

Lobbying for Independent Pharmacy Cooperative · Largest group purchasing organization for independent pharmacies.

As filed: FORBES-TATE for INDEPENDENT PHARMACY COOPERATIVE.

All filings by Forbes-Tate · Everything Independent Pharmacy Cooperative has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 15, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
Wisconsin

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Health Issues

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act.

Pharmacy

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act.

Medicare/Medicaid

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act.

 Bills named in this filing 2
  • S. 891
    Bipartisan Health Care Act
  • S. 927
    Protecting Pharmacies in Medicaid Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem